Paul Martin joins as Group Finance Director

4 January 2016

Immunodiagnostic Systems Holdings plc

Paul Martin joins as Group Finance Director

Immunodiagnostic Systems Holdings plc ("IDS" or the "Company"), a leading solution provider to the clinical laboratory diagnostic market, announces that Paul Martin has officially joined the board of IDS and taken up his position as Group Finance Director.

For further information:

About Immunodiagnostic Systems Holdings PLC:

The Group's vision is to be a leading solution provider to the clinical laboratory diagnostic market. IDS's strategy is focused on developing, internally and through partnership, its automated assay menu for its proprietary automated immunoassay analyser, the IDS-iSYS system. Internally the Group is focused on developing an endocrinology excellence menu and externally IDS works with partners to develop assay panels in complementary indication fields. The Group sells its products primarily in the clinical laboratory market across a range of customers from reference laboratories to physician office laboratories. IDS has field sales forces in certain European countries, including France and Germany, the United States and Brazil and works with distributors in other markets including China, Italy and Spain.